Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Maternal diabetes leads to unphysiological high lipid accumulation in rabbit preimplantation embryos.

Endocrinology | 2014

According to the "developmental origin of health and disease" hypothesis, the metabolic set points of glucose and lipid metabolism are determined prenatally. In the case of a diabetic pregnancy, the embryo is exposed to higher glucose and lipid concentrations as early as during preimplantation development. We used the rabbit to study the effect of maternal diabetes type 1 on lipid accumulation and expression of lipogenic markers in preimplantation blastocysts. Accompanied by elevated triglyceride and glucose levels in the maternal blood, embryos from diabetic rabbits showed a massive intracellular lipid accumulation and increased expression of fatty acid transporter 4, fatty acid-binding protein 4, perilipin/adipophilin, and maturation of sterol-regulated element binding protein. However, expression of fatty acid synthase, a key enzyme for de novo synthesis of fatty acids, was not altered in vivo. During a short time in vitro culture of rabbit blastocysts, the accumulation of lipid droplets and expression of lipogenic markers were directly correlated with increasing glucose concentration, indicating that hyperglycemia leads to increased lipogenesis in the preimplantation embryo. Our study shows the decisive effect of glucose as the determining factor for fatty acid metabolism and intracellular lipid accumulation in preimplantation embryos.

Pubmed ID: 24428528 RIS Download

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


A-FABP (B-4) (antibody)

RRID:AB_10650265

This monoclonal targets A-FABP (B-4)

View all literature mentions

Fatty Acid Synthase (A-5) (antibody)

RRID:AB_2231427

This monoclonal targets Fatty Acid Synthase (A-5)

View all literature mentions

SREBP-1 antibody (mAb) (antibody)

RRID:AB_2616606

This monoclonal targets SREBP-1

View all literature mentions

Goat Anti-Rabbit Immunoglobulins/HRP (antibody)

RRID:AB_2617138

This polyclonal secondary targets Immunoglobulins

View all literature mentions

Goat F(ab')2 anti-Mouse IgG (H+L)-HRPO (antibody)

RRID:AB_2617176

This polyclonal targets Mouse IgG (H+L)

View all literature mentions

Anti-β-Actin Antibody (antibody)

RRID:AB_476744

This monoclonal targets slightly modified β-cytoplasmic actin N-terminal peptide, Ac-Asp-Asp-Asp-Ile-Ala-Ala-Leu-Val-Ile-Asp-Asn-Gly-Ser-Gly-Lys, conjugated to KLH

View all literature mentions